|
MORNING SESSION |
|
|
07:30-09:00AM |
Breakfast / Networking |
|
|
09:00-09:15AM |
Welcoming Remark |
|
|
Yanhong Lin, Managing Partner, CTIC Capital
Victor Shi, BayHelix Chairmen; General Partner, Serica Partners |
|
09:15-09:45AM |
Keynote: The Chinese Pharmaceutical Industry: Innovation and Policy Reform |
|
|
Ruilin Song, Executive President, China Pharmaceutical Innovation and Research Development Association (PhIRDA) |
|
09:45-09:55AM |
Fireside Chat with President Song, PhIRDA |
|
|
Kevin Chen, Managing Partner, Biotrack Capital |
|
09:55-10:45AM |
Panel Discussion I: Trends in Therapeutic Investments and Partnerships |
|
|
Keting Chu, Venture Partner, LYFE Capital
Tao Fu, President and COO, Zai Lab
James Huang, Managing Partner, KPCB China; Managing Partner, Panacea Venture
Hongbo Lu, Partner, Lilly Asia Ventures
Timothy Lu, Associate Professor of Biological Engineering and Electrical Engineering and Computer Science, MIT
Vincent Xiang, Managing Director, Hillhouse Capital |
|
10:45-11:30AM |
Panel Discussion II: The Age of the Cross-Border Collaborations – Opportunities and Challenges |
|
|
Nisa Leung, Managing Partner, Qiming Venture Partners
Xiaobo Lu, Partner, Sequoia Capital China
Jonathan Wang, Partner, OrbiMed
Kevin Xie, President of Fosun Healthcare Holdings, Chief Representative of Fosun US
Jianbin Zhang, Partner, IDG Capital
James Zhao, Founding Partner, LYFE Capital |
|
11:30-01:00PM |
Lunch / Special Session Hosted by WSGR: CFIUS Reform - Navigating Its Impact on Healthcare Industry |
|
|
Joshua Gruenspecht, Of Counsel, Regulatory and Compliance, WSGR
James Jensen, Partner, Corporate, WSGR
Barry Taylor, Partner, Corporate, WSGR
Karen Wong, Partner, Intellectual Property, WSGR |
|
AFTERNOON SESSION |
|
|
01:00-01:35PM |
Keynote: Challenges and Opportunities in the Healthcare Industry |
|
|
Feng Deng, Founding Managing Director, Northern Light Venture Capital |
|
01:35-02:50PM |
Company Presenting Session I - Hosted by Josh Berlin, Biocentury |
|
|
Bigfoot Biomedical / Michael Fu, Managing Director, China Everbright Holding
Genosco / Tong Zhang, Managing Director, C-Bridge Capital
HYCOR BioMedical / Bosun Hau, Managing Director and Partner, Sailing Capital
Mesoblast / Stella Xu, Managing Director, Quan Capital
NeuroRx / Hai Mi, Founding Managing Partner, Panacea Ventures |
|
02:50-03:35PM |
Panel Discussion III: Asian Exit Opportunities in Healthcare |
|
|
Jenny Liu, Director, Corporate Finance, Haitong International Capital Limited
Bin Li, Partner and Managing Director, Ally Bridge Group
Cherry Lu, Partner, Red Hill Capital
Andrew Ng, Managing Director, Head of Healthcare, Private Equity, VMS Investment Group
Nick Pliam, Partner, Decheng Capital
Richard Zhao, Partner, Tasly International Capital |
|
03:35-04:35PM |
Company Presenting Session II - Hosted by Josh Berlin, BioCentury |
|
|
Oncolmmune / Keting Chu, Venture Partner, LYFE Capital
Oxford BioTherapeutics / Wei Wu, Healthcare Investment Director, BOE Ventures
Sirnaomics / Pei Zhou, Partner, Pagoda Capital Partners
Travera / Xiaofang Hu, Managing Director, CD Capital |
|
04:35-05:20PM |
Panel Discussion IV : Investment Opportunities: In Vitro Diagnostics and Medical Devices |
|
|
Lu Zhang, Founder and Managing Partner, Fusion Fund
Ted Driscoll, Managing Director, DigitalDX Ventures
Feng Han, Managing Director, Fosun Group
Bosun Hau, Managing Director & Partner, Sailing Capital
Alexis Ji, Partner, Illumina Ventures
Ruilin Zhao, Partner, CD Capital |
|
05:20-05:30PM |
Closing Remarks and Raffle |
|
|
Guo-Liang Yu, Co-founder, CBT Pharmaceuticals; Venture Partner, OrbiMed |
|
MORNING SESSION |
|
|
10:00-11:40AM |
Company Presentation |
|
AFTERNOON SESSION |
|
|
02:00-05:00PM |
Company Presentation |
|
|